A high prevalence of chronic hepatitis C virus (HCV) infection has recently been shown in a subset of B-cell non-Hodgkin's lymphomas, most of which belong to the lymphoplasmacytoid lymphoma/immunocytoma subtype and are characterized by the production of a monoclonal IgM cryoglobulin with rheumatoid factor activity. To better define the stage of differentiation of the malignant B cell and to investigate the role of chronic antigen stimulation in the pathogenesis of the HCV-associated immunocytomas, we analyzed the variable (V) region gene repertoire in 16 cases with this type of tumor. The lymphoma-derived V gene sequences were successfully determined in 8 cases; 5 of them expressed the 51p1 VH gene in combination with the kv325 VL gene. Moreover, a monoclonal 51p1-expressing B-cell population was detected in 4 of the remaining immunocytomas by an allele-specific Ig gene fingerprinting assay, indicating that HCV-associated immunocytomas represent clonal proliferations of a highly selected B-cell population. Somatic mutations and intraclonal diversity were observed in all of the lymphoma V genes, and clonally related IgM and IgG VH transcripts indicative of isotype switching were present in one case. These findings are consistent with an antigen-driven process and support a role for chronic antigen stimulation in the growth and clonal evolution of HCV-associated immunocytomas.

THE HEPATITIS C VIRUS (HCV) has recently been recognized as the major etiologic factor of Type II mixed cryoglobulinemia (MC).1,2 This chronic immune-complex–mediated disease is characterized by an underlying proliferation of monoclonal B cells which typically secrete a cryoprecipitable IgMk rheumatoid factor (RF).3,4 Type II MC frequently evolves into overt B-cell non-Hodgkin's lymphoma (NHL), suggesting that chronic HCV infection can lead to both a benign and a malignant lymphoproliferative disorder.5 6 

Recent studies have also shown a high prevalence of anti-HCV antibodies and HCV viremia in unselected patients with NHL, which in some series from Italy exceeded 30% of the cases.7,8 More detailed analysis of the prevalence of HCV in different histological subtypes of NHL have shown that almost half of the cases belong to the lymphoplasmacytoid lymphoma/immunocytoma subtype.9-12 This type of tumor consists of a diffuse proliferation of small lymphoid cells which show maturation to plasma cells and characteristically express surface IgM and B-cell–associated antigens but lack CD5. The sites of tumor involvement include bone marrow (BM), lymph nodes (LN), spleen, and frequently peripheral blood (PB), and a monoclonal serum paraprotein of the IgM type is present in the majority of patients.13 Other types of NHLs that have been reported to be associated with a chronic HCV infection include diffuse large cell–lymphoma and mucosa-associated lymphoid tissue (MALT) lymphoma.14-19 However, regardless of the histological subtype, it seems that more than 50% of the patients with HCV-associated lymphomas have detectable levels of cryoglobulins in their sera.9,11,12 17 

Although considerable amount of data has accumulated that supports a strong association between HCV and certain lymphoproliferative disorders, very little is known about the mechanism through which the virus could induce the expansion of particular B-cell clones. The most plausible mechanism is that certain B-cell clones proliferate as a consequence of chronic antigen stimulation either by the virus alone or by HCV-containing immune complexes.20 To investigate the role of antigen stimulation in the development of malignant HCV-associated lymphoproliferations, we have analyzed the variable region gene repertoire of 16 immunocytomas, among which 13 secreted a cryoprecipitable IgMk RF. The VH and VL gene sequences were successfully determined in 8 and 7 cases, respectively, and 5 cases were found to coexpress the 51p1 VH gene with the kv325 VL gene. Somatic mutations were detected in all of the lymphoma V gene sequences, supporting a role for antigen stimulation in the growth and clonal evolution of these tumors.

Patients' characteristics and histopathologic evaluation.

Sixteen patients with lymphoplasmacytoid lymphoma/immunocytoma and a chronic HCV infection were included in the study population. Diagnosis of lymphoma was based on clinical findings (lymphadenopathy, splenomegaly, and/or cytopenia), histopathologic evaluation of LN and/or BM biopsies, and immunophenotypic analysis for surface B- and T-lymphocytic markers. Basic workup at diagnosis included a detailed history, physical examination, hematologic parameters, standard metabolic profile, urinalysis, and thoraco-abdominal computed tomographic scans. BM biopsies were performed in all patients with a Jamshidi's needle, fixed in B5 solution for 2 hours, decalcified in Decal for two hours, and embedded in paraffin. From each block representative sections were cut and stained with Hematoxilin and Eosin (H&E), Giemsa, periodic acid–Schiff, and Pearls and Gomori. The percentage of neoplastic infiltrate and the pattern of infiltration were assessed by two different hemopathologists. Paraffin sections were used for immunohistochemical staining with the avidin-biotin-peroxidase complex method with the following monoclonal antibodies (MoAbs): anti-CD45, anti-CD20, anti-IgM, anti-IgD, anti-IgG, anti-IgA, anti-κ, and anti-λ Ig light chain (all from DAKO, Glostrup, Denmark). LN biopsies were performed as clinically indicated. Histological material was fixed in formalin and routinely processed (embedded in paraffin and stained with H&E). BM and PB lymphocytes were also analyzed by flowcytometry with MoAbs against CD19, CD20, CD5, SmIg, and κ and λ light chains (all from Becton Dickinson, Mountain View, CA). Double-immunofluorescence labeling with anti-CD5 and anti-CD19 was performed in all cases to exclude B-cell chronic lymphocytic leukemia. The lymphomas were classified according to the Revised European-American Classification of Lymphoid Neoplasms,13based on the presence of lymphoid infiltrates consisting of small ovoid lymphocytes, plasmacytoid lymphocytes, and plasma cells. The lymphoid cells showed CD20 positivity and light chain restriction, whereas the plasmacytoid and plasma cells were positive for cytoplasmatic Ig.

Serum anti-HCV antibodies and HCV RNA were detected in all patients by enzyme-linked immunosorbent assay (HCV 2.0; Ortho Diagnostic Systems, Raritan, NJ) and reverse transcription/polymerase chain reaction (RT/PCR),9,11 respectively. The HCV genotypes were determined as described elsewhere.9 11 A monoclonal IgMκ component was detected in the serum of 15 patients. Serum rheumatoid factor (normal value < 40 IU/mL) and circulating serum cryoglobulins (considered as positive if ≥1%) were present in 13 cases. At the time of first sampling, immunophenotyping of peripheral blood lymphocytes showed a κ/λ ratio indicative of a clonally expanded B-cell population in 8 cases (SEG, SS, HAZ, MS, LC2, LC3, LC4, and LC5). Some relevant clinical and laboratory characteristics of the patients are shown in Table 1.

Table 1.

Clinical and Laboratory Findings in 16 HCV+ Patients With Lymphoplasmacytoid Lymphoma/Immunocytoma

Patient Age/ Sex Involved Sites Associated Conditions HCV Genotype Monoclonal ComponentCryoglobulins (Cryocrit %) Rheumatoid Factor (IU/L)
SEL  63/F  Spleen, BM, LN  LC  1b  IgMκ  45  
SEG  45/M  Spleen, BM, PB  CPH, Type II MC  1b IgMκ  3  124  
SS  54/M  BM, PB  CAH, Type II MC, WM, MPGN  2c  IgMκ  19  6,070  
MEL  34/F  BM CAH, Type II MC, MPGN  1b  IgMκ  3  688  
HAZ 68/M  Spleen, BM, LN, PB  LC  1b  IgMκ  1  57 
MS  67/M  Spleen, BM, LN, PB  WM  2a  IgMκ absent  <20  
FAV  50/F  BM  LC, Type II MC 1b  IgMκ  4  45  
LC1  47/M  BM  Type II MC, MPGN  2a  IgMκ  34  1,815  
LC2  68/F  Spleen, BM, PB  Type II MC  2a  IgMκ  2  125  
LC3  77/F BM, PB  Type II MC, MPGN  nd  IgMκ  2  824 
LC4  62/M  Spleen, BM, PB  CAH, Type II MC  1b IgMκ  1  109  
LC5  57/F  Spleen, BM, PB  Type II MC, WM  1b  IgMκ  15  487  
LC6  66/M  BM None  2a  absent  absent  <20  
LC7 51/M  BM  CAH, Type II MC  2a  IgMκ  35  200 
LC8  58/M  BM  Type II MC  1b  IgMκ  2  600 
LC9  40/M  Spleen, BM, PB  MPGN  2a  IgMκ absent  <20 
Patient Age/ Sex Involved Sites Associated Conditions HCV Genotype Monoclonal ComponentCryoglobulins (Cryocrit %) Rheumatoid Factor (IU/L)
SEL  63/F  Spleen, BM, LN  LC  1b  IgMκ  45  
SEG  45/M  Spleen, BM, PB  CPH, Type II MC  1b IgMκ  3  124  
SS  54/M  BM, PB  CAH, Type II MC, WM, MPGN  2c  IgMκ  19  6,070  
MEL  34/F  BM CAH, Type II MC, MPGN  1b  IgMκ  3  688  
HAZ 68/M  Spleen, BM, LN, PB  LC  1b  IgMκ  1  57 
MS  67/M  Spleen, BM, LN, PB  WM  2a  IgMκ absent  <20  
FAV  50/F  BM  LC, Type II MC 1b  IgMκ  4  45  
LC1  47/M  BM  Type II MC, MPGN  2a  IgMκ  34  1,815  
LC2  68/F  Spleen, BM, PB  Type II MC  2a  IgMκ  2  125  
LC3  77/F BM, PB  Type II MC, MPGN  nd  IgMκ  2  824 
LC4  62/M  Spleen, BM, PB  CAH, Type II MC  1b IgMκ  1  109  
LC5  57/F  Spleen, BM, PB  Type II MC, WM  1b  IgMκ  15  487  
LC6  66/M  BM None  2a  absent  absent  <20  
LC7 51/M  BM  CAH, Type II MC  2a  IgMκ  35  200 
LC8  58/M  BM  Type II MC  1b  IgMκ  2  600 
LC9  40/M  Spleen, BM, PB  MPGN  2a  IgMκ absent  <20 

Abbreviations: LC, liver cirrhosis; CAH, chronic active hepatitis; CPH, chronic persistent hepatitis; Type II MC, type II mixed cryoglobulinemia; MPGN, membranoproliferative glomerulonephritis; WM, Waldenstrom's macroglobulinemia; nd, not determined.

PCR amplification, cloning, and sequencing of VH and VL region genes.

Total cellular RNA was isolated from peripheral blood mononuclear cells (PBMC), BM aspirates, and LN biopsies using the guanidinium thiocyanate-phenol-chloroform procedure.21 The PCR amplification, cloning, and sequencing of the VH region genes has been described in detail elsewhere.22 Briefly, one μg of RNA was reverse transcribed using random hexamers and the GeneAmp RNA/PCR kit (Perkin Elmer Cetus, Norwalk, CT), and then PCR amplified with a degenerate VH FWR1 primer (hFW1: 5′ AGGTGCAGCTGGA(T)GG(C)AGTC(G)T(G)GG 3′) and a Cμ specific oligonucleotide primer (hM3: 5′ GGAAAAGGGTTGGGGCGGAT 3′) located eight nucleotides downstream from the beginning of the CH1 exon. Some samples were also amplified with the FWR1 primer used in combination with a Cγ (hcG1: 5′ GGAAGACCGATGGGCCCTTG 3′) or a Cα (hA2: 5′ CGAAGACCTTGGGGCTGGTC 3′) specific primer located in the same region of the corresponding CH1 exon as the Cμ primer. The VL region genes were amplified using an equimolar mixture of 6 Vk family-specific primers (Vk1F: 5′ GTGTGCACTCCGACATCCAGATGACCCAGTCT 3′, Vk2F: 5′ GTGTGCACTCCGATGTTGTGATGACTCAGTCT 3′, Vk3F: 5′ GTGTGCACTCCGAAATTGTGTTGACGCAGTCT 3′, Vk4F: 5′ GTGTGCACTCCGACATCGTGATGACCCAGTCT 3′, Vk5F: 5′ GTGTGCACTCCGAAACGACACTCACGCAGTCT 3′, Vk6F: 5′ GTGTGCACTCCGAAATTGTGCTGACTCAGTCT 3′) and a primer from the end of the Ck gene (hCK: 5′ CTAACACTCTCCCCTGTTGAA 3′). The amplified PCR fragments were purified by electroelution from 1.2% agarose gels, ligated in the Sma I site of pUC18 (Pharmacia LKB, Uppsala, Sweden), and used to transform Escherichia coli strain DH5α. Clones were picked randomly, and double-stranded DNA template was prepared and sequenced using the T7 Sequencing Kit (Pharmacia LKB). Candidate germline genes were assigned by searching the VBASE directory.23 The assignment of DH gene segments was performed by comparison with published germline sequences,24,25 according to the criteria used in Yamada et al.25 

Ig gene fingerprinting analysis.

The presence of an expanded B-cell clone in the PBMC and lymph node samples was investigated by a previously described isotype-specific Ig gene fingerprinting procedure,26 with small modifications. Briefly, a 20-μL aliquot of each VH PCR was labeled by primer extension with an internal 32P-labeled oligonucleotide complementary to a conserved sequence in human VH framework 3 (FW3) regions (hFW3: 5′ CTGAGGACACGGCCGTGTATTACTG 3′, codons 84 to 92). The reaction mixtures (20 μL of the PCR sample, 10 pmol/L of 32P–end-labeled primer, 200 μmol/L dNTP, 0.5 μL of GeneAmp 10 × PCR Buffer, and 1.25 U of Taq polymerase, in a final volume of 25 μL) were subjected to denaturation at 95°C for 8 minutes, annealing at 64°C for 1 minute, and extension at 72°C for 15 minutes. Two microliters of each reaction were analyzed on denaturing 6M urea 6% polyacrylamide sequencing gels, with sequencing reactions used as size markers. In some experiments the labeling reactions were performed with two radioactively labeled primers, ie, hFW3 and 51p1F (5′ GATCATCCCTATCTTTGGTACAG 3′). 51p1F is homologous to a sequence in the complementarity-determining-region 2 (CDR2) of 51p1-related alleles of the VH1-69 locus,27 and is located 113 nucleotides (nt) upstream from the hFW3 primer. With this approach the fingerprint of the 51p1-related transcripts can be related with the fingerprint of all VH transcripts. If an expanded B-cell clone expressing a 51p1-related allele is present, a dominant band will be seen in the fingerprint of 51p1-related transcripts.

Analysis of mutations.

The probability (P) that excess or scarcity of replacement (R) mutations in the CDRs or FWRs resulted by chance only was calculated with the binomial distribution model28 using Microsoft Excell software (Microsoft Corp, Redmond, WA). The gene specific CDR Rf and FWR Rf values provided in Chang and Casali29 were used instead of the more approximate value of 0.75. The P values were calculated by analyzing the mutations from each set of clonally related transcripts in toto (counting each mutation only once),28 and also by analyzing each clone individually.

Clonal VH gene rearrangements in PB, BM, and LN specimens of HCV-associated immunocytomas.

Ig gene fingerprinting analysis of IgM heavy chain transcripts was performed on mRNA extracted from PBMC, BM, and LN specimens to detect the monoclonal VH gene rearrangements of the malignant clones (Figs 1 and2). Expanded IgM-expressing B-cell clones were detected in the peripheral blood of 10 cases (MS, SS, SEG, HAZ, FAV, LC2, LC3, LC4, LC6, and LC7) and in the BM aspirates and LN biopsy of patients MS, SEG, LC4, FAV, and SEL. The rearranged lymphoma VH genes from the specimens with only a few or absent residual normal B cells (SS-PB, SEG-BM and -PB, LC2-PB, LC3-PB, HAZ-PB, LC4-BM and -PB, SEL-LN, and MS-BM and -PB) were subsequently cloned and sequenced (see below). No attempt was made to clone the lymphoma VH genes from the remaining cases because the number of polyclonal IgM+ B cells seemed to be too high to allow easy identification of the malignant clones.

Fig. 1.

Ig gene fingerprinting analysis of IgM-expressing B cells from 13 patients with HCV-associated immunocytoma. The μVH region transcripts were PCR amplified using a degenerate FW1 primer and a primer from the CH1 exon of the Cμ gene (scheme). To obtain better size fractionation and easier visualization of these fragments, radioactively labeled complementary copies of the CDR3/FW4 regions were synthesized by primer extension of a consensus 32P-labeled FW3 oligonucleotide. Autoradiograms obtained after the size separation of these fragments on sequencing polyacrylamide gel electrophoresis gels are shown in the lower part of the figure. Monoclonal B-cell populations contain a single band in the fingerprint (samples LC3-PB, SS-PB, HAZ-PB, MS-PB1, and SEG-PB1), representing the unique CDR3 length of their VHDJH rearrangement. Polyclonal B-cell populations show a ladder of bands, consistent with the different CDR3 lengths of their VHDJH rearrangements. Entirely polyclonal B-cell populations show a Gaussian distribution of the bands in the fingerprint (samples LC8-PB, LC9-PB). A band of stronger intensity, as seen in cases LC2-PB, LC6-PB, LC7-PB, MS-BM2, SEG-BM2, LC4-BM2, and LC4-PB2, indicates a monoclonal B-cell expansion within a polyclonal B-cell population. The source of the analyzed sample is indicated after each case. Samples in cases MS, SEG, and LC4 were collected at two different time points separated by more than one year (indicated as 1 and 2).

Fig. 1.

Ig gene fingerprinting analysis of IgM-expressing B cells from 13 patients with HCV-associated immunocytoma. The μVH region transcripts were PCR amplified using a degenerate FW1 primer and a primer from the CH1 exon of the Cμ gene (scheme). To obtain better size fractionation and easier visualization of these fragments, radioactively labeled complementary copies of the CDR3/FW4 regions were synthesized by primer extension of a consensus 32P-labeled FW3 oligonucleotide. Autoradiograms obtained after the size separation of these fragments on sequencing polyacrylamide gel electrophoresis gels are shown in the lower part of the figure. Monoclonal B-cell populations contain a single band in the fingerprint (samples LC3-PB, SS-PB, HAZ-PB, MS-PB1, and SEG-PB1), representing the unique CDR3 length of their VHDJH rearrangement. Polyclonal B-cell populations show a ladder of bands, consistent with the different CDR3 lengths of their VHDJH rearrangements. Entirely polyclonal B-cell populations show a Gaussian distribution of the bands in the fingerprint (samples LC8-PB, LC9-PB). A band of stronger intensity, as seen in cases LC2-PB, LC6-PB, LC7-PB, MS-BM2, SEG-BM2, LC4-BM2, and LC4-PB2, indicates a monoclonal B-cell expansion within a polyclonal B-cell population. The source of the analyzed sample is indicated after each case. Samples in cases MS, SEG, and LC4 were collected at two different time points separated by more than one year (indicated as 1 and 2).

Close modal
Fig. 2.

Ig gene fingerprinting analysis of IgM (μ), IgG (γ), and IgA (α) heavy chain transcripts present in a neoplastic lymph node and a PB sample obtained from patient SEL. A dominant band corresponding to the lymphoma VH gene rearrangement can be seen in the fingerprint of the μ and γ transcripts from the lymph node. A prominent band of the same size is present in the fingerprint of μ transcripts expressed by PB lymphocytes. Sequencing reactions were used as markers to determine the exact sizes of the bands.

Fig. 2.

Ig gene fingerprinting analysis of IgM (μ), IgG (γ), and IgA (α) heavy chain transcripts present in a neoplastic lymph node and a PB sample obtained from patient SEL. A dominant band corresponding to the lymphoma VH gene rearrangement can be seen in the fingerprint of the μ and γ transcripts from the lymph node. A prominent band of the same size is present in the fingerprint of μ transcripts expressed by PB lymphocytes. Sequencing reactions were used as markers to determine the exact sizes of the bands.

Close modal
Fig. 3.

Deduced amino acid sequences of immunocytoma VH genes. The amino acid sequences of the most homologous germline VH genes are shown above the lymphoma sequences. Dashes indicate sequence identity. Amino acid replacement mutations are shown as upper case letters. The location of silent mutations in the nucleotide sequence is indicated with lower case letters. PB, BM, and LN indicate the tissue from which the lymphoma VH sequence was obtained. Sequences labeled with an asterisk were obtained from an independent set of RT/PCR, cloning, and sequencing reactions. The IgG VH sequences from SEL are labeled gSEL.

Fig. 3.

Deduced amino acid sequences of immunocytoma VH genes. The amino acid sequences of the most homologous germline VH genes are shown above the lymphoma sequences. Dashes indicate sequence identity. Amino acid replacement mutations are shown as upper case letters. The location of silent mutations in the nucleotide sequence is indicated with lower case letters. PB, BM, and LN indicate the tissue from which the lymphoma VH sequence was obtained. Sequences labeled with an asterisk were obtained from an independent set of RT/PCR, cloning, and sequencing reactions. The IgG VH sequences from SEL are labeled gSEL.

Close modal

The IgG and IgA heavy chain transcripts in the samples with a monoclonal IgM+ B-cell population were similarly analyzed with the fingerprinting procedure to investigate the occurrence of immunoglobulin isotype switching in HCV-associated immunocytoma. A prominent band with an identical CDR3 length as the IgM-derived VH gene sequence was detected in the IgG fingerprint of the lymph node sample from patient SEL (Fig 2). Subsequent cloning and sequencing of the PCR products showed clonal filiation of the IgM and IgG VH gene sequences, demonstrating that a subset of the lymphoma B cells had undergone Ig heavy-chain class switching (Fig3). The inability to detect IgG- or IgA-expressing immunocytoma B cells in the remaining cases could be caused by limitations in the sensitivity of the technique, and does not imply that isotype switching is an infrequent event in HCV-associated immunocytoma.

Fig. 4.

Deduced amino acid sequences of immunocytoma VL genes. The amino acid sequences of the most homologous germline VL genes are shown above the lymphoma sequences. Dashes indicate sequence identity. Amino acid replacement mutations are shown as upper case letters. The location of silent mutations in the nucleotide sequence is indicated with lower case letters.

Fig. 4.

Deduced amino acid sequences of immunocytoma VL genes. The amino acid sequences of the most homologous germline VL genes are shown above the lymphoma sequences. Dashes indicate sequence identity. Amino acid replacement mutations are shown as upper case letters. The location of silent mutations in the nucleotide sequence is indicated with lower case letters.

Close modal
VH gene sequences of HCV-associated immunocytomas.

Complete nucleotide sequences of the productive VHDJH gene rearrangements were obtained for eight cases; the deduced amino acid sequences are shown in Fig 3. At least three randomly selected clones from each VH PCR were sequenced, and in most of the cases all of the VH gene sequences from a single patient were clonally related (Fig 3 and Table2). In three cases (SEG, LC4, and MS) the tumor-derived VH gene sequences were obtained from both a BM and a PB sample which were collected at two different time points separated by more than 1 year. The length of the CDR3 region of the predominant VH sequence was identical to the size of the major (or unique) band in the Ig gene fingerprint in all cases.

Table 2.

Distribution of Mutations in VH Genes of HCV-Associated Lymphomas

Patient VH Family Tumor Seq/ Clones Seq (Source) VH Gene % HomologyR:S Mutations P*D GeneJH Gene
SS  VHI  4/4 (PB) 51p1  99.0  CDR  2:0  .27  DN4  JH4b 
     FWR  2:1  .1  
SEG  VH4/5 (BM) 2/3 (PB) 51p1  96.3  CDR FWR  3:3 3:3 .25 .004  DK1  JH4b  
LC2  VHI  6/8 (PB)  51p1  95.6  CDR  4:3  .14  DXP1 JH4b  
     FWR  8:7  .0008 
LC3  VHI  4/4 (PB)  51p1  97.7  CDR 2:3  .11  DN4  JH3b  
     FWR  6:5  .004  
HAZ  VHI  3/3 (PB)  51p1  99.1  CDR  1:1  .4  D21-9 JH5b  
     FWR  1:0  .19 
LC4  VHIV  4/6 (BM) 4/4 (PB) VH4.21  95.6  CDR FWR  4:2 3:4 .19 .0002  DA1/D22-12  JH2  
SEL  VHIII 9/10 (LN)  DP51  95.2  CDR  6:2  .13  DN1 JH6b  
     FWR  3:8  .00005 
MS  VHIII  5/6 (BM) 4/4 (PB)  DP47  93.1 CDR FWR  9:1 4:7  .026 .00005  D4  JH5a 
Patient VH Family Tumor Seq/ Clones Seq (Source) VH Gene % HomologyR:S Mutations P*D GeneJH Gene
SS  VHI  4/4 (PB) 51p1  99.0  CDR  2:0  .27  DN4  JH4b 
     FWR  2:1  .1  
SEG  VH4/5 (BM) 2/3 (PB) 51p1  96.3  CDR FWR  3:3 3:3 .25 .004  DK1  JH4b  
LC2  VHI  6/8 (PB)  51p1  95.6  CDR  4:3  .14  DXP1 JH4b  
     FWR  8:7  .0008 
LC3  VHI  4/4 (PB)  51p1  97.7  CDR 2:3  .11  DN4  JH3b  
     FWR  6:5  .004  
HAZ  VHI  3/3 (PB)  51p1  99.1  CDR  1:1  .4  D21-9 JH5b  
     FWR  1:0  .19 
LC4  VHIV  4/6 (BM) 4/4 (PB) VH4.21  95.6  CDR FWR  4:2 3:4 .19 .0002  DA1/D22-12  JH2  
SEL  VHIII 9/10 (LN)  DP51  95.2  CDR  6:2  .13  DN1 JH6b  
     FWR  3:8  .00005 
MS  VHIII  5/6 (BM) 4/4 (PB)  DP47  93.1 CDR FWR  9:1 4:7  .026 .00005  D4  JH5a 

*P is the probability for obtaining the observed number of R mutations by chance. The P values were determined with the binomial probability model by analyzing all mutations from each set of clonally related transcripts together (counting each mutation only once). However, the P values were not significantly different when each clone was analyzed separately (data not shown).

The germline counterparts of the lymphoma VH genes were assigned by searching the VBASE directory.23 Five of the VH genes shared more than 95% homology with the VHI family gene 51p1 (Table 2). Two other cases expressed VH genes most closely related to the VHIII family members DP47 and DP51, whereas the last VH gene sequence was most homologous to the VHIV family gene VH4.21.

All of the lymphoma VH genes showed numerous single nucleotide differences from the candidate germline genes (Fig 3). These nucleotide substitutions were apparently somatic mutations because they were obtained again after a second set of RT/PCR, cloning, and sequencing reactions. Moreover, many of the mutations in the lymphoma VH genes obtained from the first samplings in patients SEG, LC4, and MS were found also in the lymphoma VH sequences obtained from the second samplings. Finally, most of the mutations found in the lymph node specimen of patient SEL were shared between the clonally related IgM and IgG VH gene sequences. On the other hand, certain mutations were found only in a single clone or were shared only among some of the clones of a given VDJ rearrangement. Mutations of this kind were detected in all of the lymphomas, indicating that intraclonal heterogeneity of VH gene sequences is a frequent phenomenon in HCV-associated immunocytoma.

VL gene sequences of HCV-associated immunocytomas.

A predominant or unique VK sequence was obtained in seven cases (Fig 4). Sequencing of seven clones from the last case (patient MS) yielded seven different VKsequences. The inability to detect the lymphoma VK sequence in this case was presumably because of considerable differences with the sequence of the 5′ VK PCR primers; the VHgene of this case was most extensively mutated, and the same is likely to have happened with the lymphoma VK gene.

Fig. 5.

Allele-specific Ig gene fingerprinting of IgM-expressing B cells. A schematic representation of the procedure is shown at the top of the figure. The positions of the PCR primers (hFW1 and hM3) and the primers used for labeling the PCR products (hFW3 and 51p1F) are indicated. The autoradiograms show the analysis of peripheral blood lymphocytes from five normal controls (NC1-5) and eight cases with HCV-associated immunocytoma (a BM sample from MEL was also analyzed). The locations of the bands corresponding to 51p1 transcripts and all VH transcripts are indicated. Expanded 51p1-expressing B-cell clones can clearly be seen in cases LC1, LC6, LC7, and MEL.

Fig. 5.

Allele-specific Ig gene fingerprinting of IgM-expressing B cells. A schematic representation of the procedure is shown at the top of the figure. The positions of the PCR primers (hFW1 and hM3) and the primers used for labeling the PCR products (hFW3 and 51p1F) are indicated. The autoradiograms show the analysis of peripheral blood lymphocytes from five normal controls (NC1-5) and eight cases with HCV-associated immunocytoma (a BM sample from MEL was also analyzed). The locations of the bands corresponding to 51p1 transcripts and all VH transcripts are indicated. Expanded 51p1-expressing B-cell clones can clearly be seen in cases LC1, LC6, LC7, and MEL.

Close modal

The VL sequences were analyzed essentially as described for the VH sequences, with a minimum of three clones sequenced from each VK PCR. Five of the sequences were most homologous to the VKIII family gene kv325 (Table3). One of the remaining two cases expressed the VKIII family gene Vg, whereas the last sequence was most closely related to the VKIV family gene DPK24. Interestingly, all of the lymphoma kv325 VL genes were paired with a 51p1-derived VH gene. Somatic mutations and intraclonal diversity were also observed in the VLsequences, although to an apparently lesser extent than in the case of the lymphoma VH sequences.

Table 3.

Distribution of Mutations in VL Genes of HCV-Associated Lymphomas

Patient VL Family Tumor Seq/ Clones Seq (source) VL Gene % HomologyR:S Mutations P*JL Gene
SS  VKIII  3/3 (PB) kv325  98.9  CDR  0:0  .49  JK
     FWR  1:2  .16  
SEG VKIII  4/6 (BM) 4/4 (PB)  kv325  97.4 CDR FWR  4:1 0:1  .008 .005  JK3  
LC2  VKIII  4/5 (PB) kv325  98.9  CDR  2:0  .11  JK
     FWR  1:0  .16  
LC3 VKIII  4/4 (PB)  kv325  99.3  CDR  1:0 .27  JK1  
     FWR  0:1 .17  
HAZ  VKIII  3/3 (PB)  kv325  99.3 CDR  0:1  .7  JK2  
     FWR 0:1  .17  
LC4  VKIII  4/4 (PB)  Vg 97.0  CDR  4:0 .033  JK3  
     FWR  1:3  .004  
SEL  VKIV  3/7 (LN)  DPK24  95.4  CDR  5:3  .16  JK
     FWR  4:0  .02   
Patient VL Family Tumor Seq/ Clones Seq (source) VL Gene % HomologyR:S Mutations P*JL Gene
SS  VKIII  3/3 (PB) kv325  98.9  CDR  0:0  .49  JK
     FWR  1:2  .16  
SEG VKIII  4/6 (BM) 4/4 (PB)  kv325  97.4 CDR FWR  4:1 0:1  .008 .005  JK3  
LC2  VKIII  4/5 (PB) kv325  98.9  CDR  2:0  .11  JK
     FWR  1:0  .16  
LC3 VKIII  4/4 (PB)  kv325  99.3  CDR  1:0 .27  JK1  
     FWR  0:1 .17  
HAZ  VKIII  3/3 (PB)  kv325  99.3 CDR  0:1  .7  JK2  
     FWR 0:1  .17  
LC4  VKIII  4/4 (PB)  Vg 97.0  CDR  4:0 .033  JK3  
     FWR  1:3  .004  
SEL  VKIV  3/7 (LN)  DPK24  95.4  CDR  5:3  .16  JK
     FWR  4:0  .02   

*P is the probability for obtaining the observed number of R mutations by chance. The P values were determined with the binomial probability model by analyzing all mutations from each set of clonally related transcripts together (counting each mutation only once). However, the P values were not significantly different when each clone was analyzed separately (data not shown).

Distribution of mutations in lymphoma VH and VL genes.

To address the possible role of antigen selection in the clonal evolution of the HCV-associated immunocytomas, we investigated the distribution of replacement and silent mutations in the CDRs of the VH and VL genes. Although most of the sequences showed a higher replacement-to-silent (R:S) ratio in the CDRs than in the FWRs, the probability for obtaining the observed number of R mutations in the CDRs by chance alone was smaller than 0.05 only in the case of one VH gene (case MS) and two VL genes (cases SEG and LC4). The absence of significant clustering of replacement mutations in the CDRs argues against selection for variants with higher antigen binding affinity.28 29 On the other hand, lower numbers of R mutations than expected by chance alone were evident in most of the FWRs, indicating selective pressure for maintenance of functional Ig molecules.

Preferential expression of the 51p1 VH gene in HCV-associated immunocytomas.

The 51p1/Humkv325 gene combination was expressed in five of the eight lymphomas for which VH and VL gene sequences were determined. The remaining eight lymphomas were screened for monoclonal 51p1 rearrangements using an allele-specific Ig gene fingerprinting assay. This was performed by including a 51p1-specific oligonucleotide in the labeling step of the Ig gene fingerprinting analysis, which allows detection of a monoclonal 51p1-expressing B-cell population among IgM+ B cells expressing other VH genes (Fig 5). The specificity of this assay was previously established by analyzing more than 30 chronic lymphocytic leukemia (CLL) cases with characterized VH gene sequences (only cases with a monoclonal 51p1 rearrangement showed a single band in the 51p1 fingerprint), and more than 60 cases without any lymphoproliferative disorder (DGE, unpublished observations, July 1997). Most of the latter cases showed a polyclonal pattern of 51p1 transcripts (examples are NC1-4 in Fig 5), whereas in the remaining cases 51p1 transcripts could not be detected (NC5 in Fig5). This type of normal pattern was observed in cases LC5, LC8, LC9, and FAV, whereas the remaining four cases (LC1, LC6, LC7, and MEL) showed a dominant single band in the 51p1 fingerprint, indicating a monoclonal expansion of 51p1-expressing IgM+ B cells. Thus, it seems probable that these four lymphomas also expressed Ig molecules encoded by the 51p1 VH gene.

Nucleotide sequence analysis of VH and VL genes has provided useful information regarding the pathogenesis and the stage of differentiation for many B-cell neoplasms.30-41The presence of somatic mutations suggests that the malignant B cells have passed the germinal center stage of differentiation, whereas the finding of a restricted V gene repertoire and a high frequency of replacement mutations in the CDRs are indicative of a role for antigen selection in the pathogenesis of the disease. We now show that the antibodies expressed by the malignant B cells in HCV-associated immunocytomas are preferentially encoded by a restricted set of VH and VL genes. The 51p1/kv325 gene combination encoded the variable regions in five of the eight cases for which complete nucleotide sequences were determined. Considering also the data obtained with the Ig gene fingerprinting technique, it seems that 9 of the 16 VH genes were derived from the 51p1 gene, indicating that this VH gene is highly overrepresented in HCV-associated immunocytoma.

The frequent usage of the 51p1/kv325 combination in HCV-associated immunocytomas is not surprising, considering that the malignant B cells in most cases produced a monoclonal cryoglobulin with RF activity (8 of the 13 cases with a type II cryoglobulin had a monoclonal 51p1 rearrangement). Early studies using anti-idiotypic antibodies have shown that more than 60% of monoclonal RFs from patients with type II MC express the Wa cross-reactive idiotype (CRI), which, in turn, in more than 70% of the cases is associated with the light chain CRI 17.109 and the heavy chain CRI G6.5 The latter two CRIs are characteristic for VL and VH regions encoded by germline kv325 and 51p1 genes, respectively. Thus, these data indicate that HCV-associated immunocytoma most likely represents the malignant counterpart of type II MC.

The VH and VL gene sequences from all of the HCV-associated immunocytomas showed a number of nucleotide differences with respect to their germline counterparts. In addition, substantial intraclonal VH and/or VL gene diversity was evident in each case, consistent with an ongoing somatic hypermutation process in the tumor cells subsequent to the neoplastic transformation. A similar phenotype has been observed in a number of other B-cell malignancies such as follicular lymphoma,30gastric and salivary gland MALT lymphoma,35,40 Burkitt's lymphoma,36 and monoclonal gammopathy of undetermined significance,37 indicating that the malignant events in these neoplasms might have occurred at a similar stage of B-cell differentiation.

Clonally related transcripts of the IgM and IgG heavy chain isotype were detected in one of the HCV-associated immunocytomas, providing evidence for isotype switching in a subset of the malignant B cells. Isotype switching and somatic hypermutation are processes which typically occur in the germinal centers of lymphoid tissues during a T-cell–dependent antibody response, and are consistent with a role for antigen stimulation in the clonal evolution of the lymphoma. The RF activity of the Igs from most of the HCV-associated immunocytomas suggests that the proliferation of the neoplastic B cells was driven by immune complexes composed of polyclonal IgG and HCV. T cells specific for IgG Fc are normally deleted,42 but the RF-producing B cells may obtain T-cell help from HCV-specific T cells while presenting peptides derived from HCV proteins present in the immune complexes.43 Interestingly, however, the pattern of somatic mutations in the HCV-associated immunocytoma V genes is not suggestive for selection of changes which could increase the affinity for the antigen. Rather, the low number of replacement mutations in the CDRs is indicative of selection against mutations which could generate high-affinity antibodies. This is most clearly seen in the case of the 51p1-encoded VH regions which have an overall R:S ratio in the CDRs of only 1.2 (12:10), which is substantially lower than the R:S ratio of 3.6 expected from random accumulation of nucleotide changes in the absence of selective pressure.29 A high R:S ratio which was significantly different from the one expected for random mutations was seen only in the VH CDRs of the lymphoma immunoglobulin that lacked RF activity (patient MS, Table 2). The CDRs of the light chains similarly lacked high R:S ratios, which was especially evident in the case of the kv325-encoded VL domains. A low number of R mutations was also observed in the FWRs of most of the VH and VL domains. Negative selection against R mutations in the FWRs is consistent with selective pressure for maintenance of functional Ig molecules, and further indicates the requirement for a functional B-cell receptor in the clonal evolution of the HCV-associated immunocytomas.

Rheumatoid factor antibodies that are induced after immunization of healthy donors are frequently encoded by the 51p1/kv325 combination,44 indicating a common cellular origin with the monoclonal RFs of type II MC and HCV-associated immunocytoma. Nucleotide sequence analysis of 51p1-encoded RFs from healthy immunized donors also shows a strong selection against R mutations in the CDRs, and moreover, no increase in the affinity for the Fc region of IgG with the accumulation of mutations.45 Intraclonal diversity and absence of significant clustering of R mutations in the CDRs has also been observed in a 51p1/kv325-encoded RF from a patient with type II MC.46 Also in this case the affinity for the Fc region of IgG did not change after substituting the mutated 51p1 and kv325 genes with their germline counterparts.47 Thus, although all of the above data indicate that antigen stimulation can lead to the proliferation, somatic mutation, and isotype switching of RF-expressing B cells, it also seems that B cells expressing high affinity RF receptors are either not selected or are eliminated by peripheral tolerance mechanisms.48-50 

Preferential use of the 51p1 gene has also been observed in CLL, with a prevalence of more than 20% in particular geographic areas (31,51 and DGE, unpublished observations, July 1997). However, unlike the HCV-associated immunocytomas, the 51p1 VH sequences in CLL are almost exclusively unmutated and usually have significantly longer CDR3 regions.51,52 A more striking similarity regarding V gene repertoire and somatic hypermutation exists between HCV-associated immunocytoma and salivary gland MALT lymphoma. In two recent studies by Bahler et al40 53 the 51p1 gene was found in 10 of the 18 VH sequences and was associated with a kv325 VLregion in all cases in which the VL sequence was reported. Although the antigen specificity of the lymphoma Igs in this study is unknown, it is interesting to note that salivary gland MALT lymphomas are typically associated with Sjogren's syndrome, which is frequently characterized by the presence of RFs and cryoglobulins in patients' sera. Somatic hypermutation, intraclonal diversity, and selection against R mutations in the CDRs was also observed in this study, indicating similar events in the pathogenesis of HCV-associated immunocytomas and salivary gland MALT lymphomas.

In summary, the data presented in this study indicate that HCV-associated immunocytomas represent clonal proliferations of a highly selected B-cell population. The tumor cells from most of these cases secrete a cryoprecipitable RF that is frequently encoded by the 51p1 VH gene in combination with the kv325 VLgene. The V genes in these lymphomas undergo changes typical of a T-cell–dependent antibody response, indicating a role for chronic antigen stimulation by HCV-containing immune complexes in the clonal evolution of HCV-associated immunocytomas.

We thank Dr Nicholas Chiorazzi for valuable comments and critical reading of the manuscript.

Supported in part by a grant no. 42 from the Istituto Superiore Di Sanita within the frame of the Primo Progetto Di Ricerca Epatite Virale.

Address reprint requests to Dimitar G. Efremov, MD, PhD, ICGEB, Area Science Park, Padriciano 99, 34012 Trieste, Italy.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" is accordance with 18 U.S.C. section 1734 solely to indicate this fact.

1
Agnello
 
V
Chung
 
RT
Kaplan
 
LM
A role for hepatitis C virus infection in type II cryoglobulinemia.
N Engl J Med
327
1992
1490
2
Misiani
 
R
Bellavita
 
P
Fenili
 
D
Borelli
 
G
Marchesi
 
D
Massazza
 
M
Vendramin
 
G
Comotti
 
B
Tanzi
 
E
Scudeller
 
G
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.
Ann Intern Med
117
1992
573
3
Perl
 
A
Gorevic
 
PD
Ryan
 
DH
Condemi
 
JJ
Ruszkowski
 
RJ
Abraham
 
GN
Clonal B cell expansion in patients with essential mixed cryoglobulinemia.
Clin Exp Immunol
76
1989
54
4
Franzin
 
F
Efremov
 
DG
Pozzato
 
G
Tulissi
 
P
Batista
 
F
Burrone
 
O
Clonal B-cell expansions in peripheral blood of HCV-infected patients.
Br J Haematol
90
1995
548
5
Gorevic
 
PD
Frangione
 
B
Mixed cryoglobulinemia crossreactive idiotypes: Implications for the relationship of MC to rheumatic and lymphoproliferative disease.
Semin Hematol
28
1991
79
6
Pozzato
 
G
Mazzaro
 
C
Crovatto
 
M
Modolo
 
ML
Ceselli
 
S
Mazzi
 
G
Sulfaro
 
S
Franzin
 
F
Tulissi
 
P
Moretti
 
M
Santini
 
GF
Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia.
Blood
84
1994
3047
7
Ferri
 
C
Caracciolo
 
F
Zignego
 
AL
La Civita
 
L
Monti
 
M
Longombardo
 
G
Lombardini
 
F
Greco
 
F
Capochiani
 
E
Mazzoni
 
A
Mazzaro
 
C
Pasero
 
GP
Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
Br J Haematol
88
1994
392
8
Luppi
 
M
Ferrari
 
MG
Bonaccorsi
 
G
Longo
 
G
Narni
 
F
Barozzi
 
P
Marasca
 
R
Mussini
 
C
Torelli
 
G
Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Leukemia
10
1996
351
9
Silvestri
 
F
Pipan
 
C
Barillari
 
G
Zaja
 
F
Fanin
 
R
Infanti
 
L
Russo
 
D
Falasca
 
E
Botta
 
GA
Baccarani
 
M
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
Blood
87
1996
4296
10
(letter)
Musto
 
P
dell'Olio
 
M
Carotenuto
 
M
Mangia
 
A
Andriulli
 
A
Hepatitis C virus infection: A new bridge between hematologists and gastroenterologists?
Blood
88
1996
752
11
Mazzaro
 
C
Zagonel
 
V
Monfardini
 
S
Tulissi
 
P
Pussini
 
E
Fanni
 
M
Sorio
 
R
Bortolus
 
R
Crovatto
 
M
Santini
 
G
Tiribelli
 
C
Sasso
 
F
Masutti
 
R
Pozzato
 
G
Hepatitis C virus and non-Hodgkin's lymphomas.
Br J Haematol
94
1996
544
12
Silvestri
 
F
Barillari
 
G
Fanin
 
R
Pipan
 
C
Falasca
 
E
Salmaso
 
F
Zaja
 
F
Infanti
 
L
Patriarca
 
F
Botta
 
GA
Baccarani
 
M
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Haematologica
82
1997
314
13
Harris
 
NL
Jaffe
 
ES
Stein
 
H
Banks
 
PM
Chan
 
JKC
Cleary
 
ML
Delsol
 
G
Dewolf-Peeters
 
C
Falini
 
B
Gatter
 
KC
Grogan
 
TM
Isaacson
 
PG
Knowles
 
DM
Mason
 
DY
Muller-Hermelink
 
HK
Pileri
 
SA
Piris
 
MA
Ralfkiaer
 
E
Warnke
 
RA
A Revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group.
Blood
84
1994
1361
14
Pioltelli
 
P
Zehender
 
G
Monti
 
G
Monteverde
 
A
Galli
 
M
HCV and non-Hodgkin's lymphoma.
Lancet
347
1996
624
15
Luppi
 
M
Longo
 
G
Ferrari
 
MG
Ferrara
 
L
Marasca
 
R
Barozzi
 
P
Morselli
 
M
Emilia
 
G
Torelli
 
G
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type.
Br J Haematol
94
1996
373
16
De Vita
 
S
Sansonno
 
D
Dolcetti
 
R
Ferraccioli
 
G
Carbone
 
A
Cornacchiulo
 
V
Santini
 
G
Crovatto
 
M
Gloghini
 
A
Dammacco
 
F
Boiocchi
 
M
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia.
Blood
86
1995
1887
17
De Vita
 
S
Sacco
 
C
Sansono
 
D
Gloghini
 
A
Dammacco
 
F
Crovatto
 
M
Santini
 
G
Dolcetti
 
R
Boiocchi
 
M
Carbone
 
A
Zagonel
 
V
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection.
Blood
90
1997
776
18
(abstr)
Zuckerman
 
T
Zuckerman
 
E
Douer
 
D
Fong
 
T-L
Nathwani
 
BN
Velankar
 
M
Gutenkunst
 
K
Qian
 
GD
Levine
 
AM
Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
Blood
88
1996
222a
19
(letter)
Silvestri
 
F
Barillari
 
G
Fanin
 
R
Salmaso
 
F
Infanti
 
L
Zaja
 
F
Baccarani
 
M
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas.
Br J Haematol
96
1997
427
20
Agnello
 
V
The aetiology of mixed cryoglobulinemia associated with hepatitis C virus infection.
Scand J Immunol
42
1995
179
21
Chomzynski
 
P
Sacchi
 
N
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162
1987
156
22
Efremov
 
DG
Ivanovski
 
M
Siljanovski
 
N
Pozzato
 
G
Cevreska
 
L
Fais
 
F
Chiorazzi
 
N
Batista
 
FD
Burrone
 
OR
Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia.
Blood
87
1996
3869
23
Cook
 
GP
Tomlison
 
IM
The human immunoglobulin VH repertoire.
Immunol Today
16
1995
237
24
Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C: Sequences of Proteins of Immunological Interest (ed 5). Bethesda, MD, US Department of Health and Human Services, 1991
25
Yamada
 
M
Wasserman
 
R
Reichard
 
BA
Shane
 
S
Caton
 
AJ
Rovera
 
G
Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes.
J Exp Med
173
1991
395
26
Efremov
 
DG
Ivanovski
 
N
Batista
 
FD
Pozzato
 
G
Burrone
 
OR
IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.
J Clin Invest
98
1996
290
27
Sasso
 
EH
van Dijk
 
KW
Bull
 
AP
Milner
 
ECB
A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles.
J Clin Invest
91
1993
2358
28
Schlomchik
 
MJ
Aucoin
 
AH
Pisetsky
 
DS
Weigert
 
MG
Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.
Proc Natl Acad Sci USA
84
1987
9150
29
Chang
 
B
Casali
 
P
The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement.
Immunol Today
15
1994
367
30
Bahler
 
DW
Levy
 
R
Clonal evolution of a follicular lymphoma: Evidence for antigen selection.
Proc Natl Acad Sci USA
89
1992
6770
31
Kipps
 
TJ
Carson
 
DA
Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases.
Blood
81
1993
2475
32
Wagner
 
SD
Martinelli
 
V
Luzzatto
 
L
Similar patterns of Vk gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma.
Blood
83
1994
3647
33
Hsu
 
FJ
Levy
 
R
Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma.
Blood
86
1995
3072
34
Qin
 
Y
Greiner
 
A
Trunk
 
MJF
Schmausser
 
B
Ott
 
MM
Muller-Hermelink
 
HK
Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type-B-cell lymphoma.
Blood
86
1995
3528
35
Du
 
M
Diss
 
TC
Xu
 
C
Peng
 
H
Isaacson
 
PG
Pan
 
L
Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion.
Leukemia
10
1996
1190
36
Chapman
 
CJ
Zhou
 
JX
Gregory
 
C
Rickinson
 
AB
Stevenson
 
FK
VH and VL gene analysis in sporadic Burkitt's lymphoma show somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection.
Blood
88
1996
3562
37
Sahota
 
SS
Leo
 
R
Hamblin
 
TJ
Stevenson
 
FK
Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance.
Blood
87
1996
746
38
Davi
 
F
Maloum
 
K
Michel
 
A
Pritsch
 
O
Magnac
 
C
Macintyre
 
E
Salomon-Nguyen
 
F
Binet
 
J-L
Dighiero
 
G
Merle-Beral
 
H
High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemia.
Blood
88
1996
3953
39
Kuppers
 
R
Rajewsky
 
K
Hansman
 
M-L
Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutations and evidence of selection for antibody expression.
Eur J Immunol
27
1997
1398
40
Bahler
 
DW
Miklos
 
JA
Swerdlow
 
SH
Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas.
Blood
89
1997
3335
41
Sahota
 
SS
Leo
 
R
Hamblin
 
TJ
Stevenson
 
FK
Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.
Blood
89
1997
219
42
Bikoff
 
EK
Tolerance for self Ig at the level of the Ly1+ T cell.
J Exp Med
158
1983
1868
43
Roosnek
 
E
Lanzavecchia
 
A
Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
J Exp Med
173
1991
487
44
Borretzen
 
M
Randen
 
I
Natvig
 
JB
Thompson
 
KM
Structural restriction in the heavy chain CDR3 of human rheumatoid factors.
J Immunol
155
1995
3630
45
Borretzen
 
M
Randen
 
I
Zdarsky
 
E
Forre
 
O
Natvig
 
JB
Thompson
 
KM
Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.
Proc Natl Acad Sci USA
91
1994
12917
46
Crouzier
 
R
Martin
 
T
Pasquali
 
J-L
Monoclonal IgM rheumatoid factor secreted by CD5-negative B-cells during mixed cryoglobulinemia: Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.
J Immunol
154
1995
413
47
Crouzier
 
R
Martin
 
T
Pasquali
 
J-L
Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
J Immunol
154
1995
4526
48
Tighe
 
H
Heaphy
 
P
Baird
 
S
Weigle
 
WO
Carson
 
DA
Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice.
J Exp Med
181
1995
599
49
Tighe
 
H
Warnatz
 
K
Brinson
 
D
Corr
 
M
Weigle
 
WO
Baird
 
SM
Carson
 
DA
Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.
Proc Natl Acad Sci USA
94
1997
646
50
Wang
 
H
Shlomchik
 
MJ
High affinity rheumatoid factor transgenic B cells are eliminated in normal mice.
J Immunol
159
1997
1125
51
Johnson
 
TA
Rassenti
 
LZ
Kipps
 
TJ
Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
J Immunol
158
1997
235
52
Efremov
 
DG
Ivanovski
 
M
Pozzato
 
G
Batista
 
FD
Burrone
 
OR
The leukemic cells of chronic lymphocytic leukemia patients with autoimmune hemolytic anemia produce isotype-switched immunoglobulins that are preferentially encoded by the 51p1 and DP-50 VH genes.
Ann NY Acad Sci
815
1997
443
53
(abstr, suppl 1)
Bahler
 
DW
Miklos
 
JA
Kapadia
 
SB
Swerdlow
 
SH
Preferential use of specific immunoglobulin VH, D and JH genes by salivary gland MALT lymphomas.
Blood
88
1996
375a
Sign in via your Institution